The foundation of sustained graft protection and long-term immunologic control in kidney transplantation relies on consistent and optimized maintenance immunosuppression. Through expert presentations, interactive case discussions, and reviews of contemporary evidence and current guideline recommendations, the symposium will examine the clinical implications of formulation changes in narrow therapeutic index agents, the impact of intra-patient variability on drug exposure and graft outcomes, and the role of formulation consistency in supporting optimal immunosuppressive management. The symposium will conclude with a discussion exploring practical strategies for enhancing consistency in routine kidney transplant practice.